Latus Pharma ApS: Financial statements 2019
CVR: 36974214
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Latus Pharma ApS (CVR 36974214) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -4,111 and a net result of DKK -4,111 compared with DKK -4,352 the year before. Equity in the 2019 report amounted to DKK 126,761. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -4,111
- Profit/Loss
- DKK -4,111
- Equity
- DKK 126,761
- Total Assets
- DKK 126,761
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | -4 t. | -4 t. | 127 t. | - |
| 2018 | 0 | -4 t. | -4 t. | 131 t. | - |
| 2017 | 11 t. | -65 t. | -65 t. | 135 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Latus Pharma ApS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -4,352.
About Latus Pharma ApS
Latus Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jørgen Wittendorff. The company is owned by Jørgen Wittendorff. In 2025, the company reported revenue of DKK -6,991 and a net result of DKK -6,991 compared with DKK -6,897 the year before. Equity in the 2025 report amounted to DKK 82,569.